GangaGen’s Antibiotic Gets U.S. Patent (RedNova)
GangaGen’s Antibiotic Gets U.S. Patent (RedNova)
GangaGen said Wednesday its bacteriophage technology, which is being developed for bacterial infections, was awarded a U.S. patent. The patent covers the use of lysine-deficient bacteriophages for destroying pathogenic bacteria, including those resistant to antibiotics.